Skip to main content
Premium Trial:

Request an Annual Quote

Addtech Acquires Reagent, Instrument Firm BioNordika

NEW YORK (GenomeWeb News) – Swedish firm Addtech Life Science today announced it has acquired BioNordika Holding.

Addtech Life Science is a business area in the Addtech Group. BioNordika Holding is the parent company of the BioNordika Group, which markets reagents and instruments for biomedical research, primarily to the pharmaceutical industry and public institutions.

BioNordika Group has subsidiaries in Denmark, Estonia, Finland, Norway, and Sweden. It has 24 employees and SEK80 million ($11.8 million) in sales.

The purchase is expected to be complementary to Addtech Life Science's Diagnostic Business Unit, which sells reagents and equipment to healthcare laboratories in the Nordic region.

The deal, which closes today, is anticipated to be "marginally" accretive to Addtech Life Science's earnings per share in the current year, it said.

Terms of the acquisition were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.